Mavi H1 2026 slides: margins expand amid Turkey retail headwinds

Mavi shares rose 8.75% to $37.30 after Q2 2026 EBITDA increased 4% to TRY2.07 billion and EBITDA margin expanded 70bps to 16.4%, despite consolidated revenue declining 0.4% year over year. H1 revenue fell 1.1% to TRY25.83 billion under IAS 29 inflation accounting, but gross margin rose 180bps to 53.1%, operating cash flow reached TRY4.22 billion, and net cash stood at TRY6.66 billion. Management cut full-year revenue guidance to a low-single-digit decline to flat amid higher Turkish inflation, while retaining its 18.0% ± 0.5% EBITDA-margin target and approving a TRY1 billion share-buyback program.

Analysis

The investable signal is not the reported profit beat but the durability of gross-margin defense as Turkish consumer purchasing power remains impaired. A retailer holding margin while real basket values weaken is likely harvesting mix, sourcing and inventory gains that become harder to repeat once promotional intensity normalizes; fixed-cost deleverage can reappear quickly if volume momentum slows. The near-term re-rating case therefore depends on evidence that back-to-school demand converts into sustained full-price sell-through rather than a calendar-driven rebound.

The buyback and net-cash position create downside support, but capital returns should not be treated as a substitute for top-line recovery. The more consequential 6-18 month optionality is North American scaling: successful store productivity and wholesale sell-through could shift the valuation framework away from Turkey macro risk, while execution failure would leave the company with higher fixed costs and limited domestic growth. Currency translation, inflation-accounting distortions and an elevated tax burden make reported net income a poor valuation anchor; cash conversion, inventory turns and EBITDA margin are the cleaner monitoring variables.

There is no fundamental read-through to APP or SMCI despite their inclusion in the supplied ticker set. Treat the article's promotional references and AI-stock marketing as non-investment content rather than a catalyst for either name.

Key Decisions for Investors

• No action in APP or SMCI: neither has an identifiable earnings, demand, supply-chain or valuation linkage to this retailer update.
• For investors able to trade Borsa Istanbul-listed Mavi, use a 1-3 month watch-entry rather than chase the post-results move: initiate only if September/October like-for-like volume remains positive while EBITDA margin holds at or above the guided range. The missing confirmation is full-price sell-through and inventory aging after the back-to-school period.
• Size any Mavi long as a high-macro-risk consumer position, with a 6-12 month thesis centered on international unit economics and cash returns rather than domestic nominal sales growth. Falsify on two consecutive quarters of margin contraction, renewed inventory build versus sales, or a guidance cut below the current margin range.
• Avoid pairing the name against broad Turkish consumer retail without comparable disclosure on inflation accounting, currency exposure and channel mix; apparent relative valuation discounts can be accounting-driven rather than evidence of mispricing.